175 related articles for article (PubMed ID: 38483821)
41. Magnetic/NIR-responsive drug carrier, multicolor cell imaging, and enhanced photothermal therapy of gold capped magnetite-fluorescent carbon hybrid nanoparticles.
Wang H; Cao G; Gai Z; Hong K; Banerjee P; Zhou S
Nanoscale; 2015 May; 7(17):7885-95. PubMed ID: 25854197
[TBL] [Abstract][Full Text] [Related]
42. Complementing Cancer Photodynamic Therapy with Ferroptosis through Iron Oxide Loaded Porphyrin-Grafted Lipid Nanoparticles.
Liang X; Chen M; Bhattarai P; Hameed S; Tang Y; Dai Z
ACS Nano; 2021 Dec; 15(12):20164-20180. PubMed ID: 34898184
[TBL] [Abstract][Full Text] [Related]
43. Cell-Penetrating Peptidic GRP78 Ligand-Conjugated Iron Oxide Magnetic Nanoparticles for Tumor-Targeted Doxorubicin Delivery and Imaging.
Hasani M; Jafari S; Akbari Javar H; Abdollahi H; Rashidzadeh H
ACS Appl Bio Mater; 2023 Mar; 6(3):1019-1031. PubMed ID: 36862384
[TBL] [Abstract][Full Text] [Related]
44. Lutein-loaded chitosan/alginate-coated Fe
Bulatao BP; Nalinratana N; Jantaratana P; Vajragupta O; Rojsitthisak P; Rojsitthisak P
Int J Biol Macromol; 2023 Jul; 242(Pt 1):124673. PubMed ID: 37137353
[TBL] [Abstract][Full Text] [Related]
45. Glucose oxidase and polydopamine functionalized iron oxide nanoparticles: combination of the photothermal effect and reactive oxygen species generation for dual-modality selective cancer therapy.
Zhang T; Li Y; Hong W; Chen Z; Peng P; Yuan S; Qu J; Xiao M; Xu L
J Mater Chem B; 2019 Apr; 7(13):2190-2200. PubMed ID: 32073578
[TBL] [Abstract][Full Text] [Related]
46. Ferroptosis-enhanced chemotherapy for triple-negative breast cancer with magnetic composite nanoparticles.
Zhang J; Zhou K; Lin J; Yao X; Ju D; Zeng X; Pang Z; Yang W
Biomaterials; 2023 Dec; 303():122395. PubMed ID: 37988899
[TBL] [Abstract][Full Text] [Related]
47. DNA binding and cytotoxicity studies of magnetic nanofluid containing antiviral drug oseltamivir.
Shahabadi N; Shadkam M; Mansouri K
J Biomol Struct Dyn; 2019 Jul; 37(11):2980-2988. PubMed ID: 30035676
[TBL] [Abstract][Full Text] [Related]
48. Aqueous-phase synthesis of iron oxide nanoparticles and composites for cancer diagnosis and therapy.
Li J; Wang S; Shi X; Shen M
Adv Colloid Interface Sci; 2017 Nov; 249():374-385. PubMed ID: 28335985
[TBL] [Abstract][Full Text] [Related]
49. Cytotoxic consequences of Halloysite nanotube/iron oxide nanocomposite and iron oxide nanoparticles upon interaction with bacterial, non-cancerous and cancerous cells.
Abhinayaa R; Jeevitha G; Mangalaraj D; Ponpandian N; Vidhya K; Angayarkanni J
Colloids Surf B Biointerfaces; 2018 Sep; 169():395-403. PubMed ID: 29803155
[TBL] [Abstract][Full Text] [Related]
50. Synthesis, Characterization, and Study of In Vitro Cytotoxicity of ZnO-Fe3O4 Magnetic Composite Nanoparticles in Human Breast Cancer Cell Line (MDA-MB-231) and Mouse Fibroblast (NIH 3T3).
Bisht G; Rayamajhi S; Kc B; Paudel SN; Karna D; Shrestha BG
Nanoscale Res Lett; 2016 Dec; 11(1):537. PubMed ID: 27914092
[TBL] [Abstract][Full Text] [Related]
51. Cytotoxic effects and apoptosis induction of cisplatin-loaded iron oxide nanoparticles modified with chitosan in human breast cancer cells.
Morovati A; Ahmadian S; Jafary H
Mol Biol Rep; 2019 Oct; 46(5):5033-5039. PubMed ID: 31278563
[TBL] [Abstract][Full Text] [Related]
52. (99m)Tc-labeled aminosilane-coated iron oxide nanoparticles for molecular imaging of ανβ3-mediated tumor expression and feasibility for hyperthermia treatment.
Tsiapa I; Efthimiadou EK; Fragogeorgi E; Loudos G; Varvarigou AD; Bouziotis P; Kordas GC; Mihailidis D; Nikiforidis GC; Xanthopoulos S; Psimadas D; Paravatou-Petsotas M; Palamaris L; Hazle JD; Kagadis GC
J Colloid Interface Sci; 2014 Nov; 433():163-175. PubMed ID: 25128864
[TBL] [Abstract][Full Text] [Related]
53. Toxicological effects of the mixed iron oxide nanoparticle (Fe
Alves Feitosa K; de Oliveira Correia R; Maragno Fattori AC; Albuquerque YR; Brassolatti P; Flores Luna G; de Almeida Rodolpho JM; T Nogueira C; Cancino Bernardi J; Speglich C; de Freitas Anibal F
J Toxicol Environ Health A; 2022 Aug; 85(16):649-670. PubMed ID: 35469539
[TBL] [Abstract][Full Text] [Related]
54. Superparamagnetic Iron Oxide Nanoparticles Induce Apoptosis in HT-29 Cells by Stimulating Oxidative Stress and Damaging DNA.
Ranjbary AG; Saleh GK; Azimi M; Karimian F; Mehrzad J; Zohdi J
Biol Trace Elem Res; 2023 Mar; 201(3):1163-1173. PubMed ID: 35451693
[TBL] [Abstract][Full Text] [Related]
55. Release of a liver anticancer drug, sorafenib from its PVA/LDH- and PEG/LDH-coated iron oxide nanoparticles for drug delivery applications.
Ebadi M; Bullo S; Buskara K; Hussein MZ; Fakurazi S; Pastorin G
Sci Rep; 2020 Dec; 10(1):21521. PubMed ID: 33298980
[TBL] [Abstract][Full Text] [Related]
56. Different sensitivities of senescent breast cancer cells to immune cell-mediated cytotoxicity.
Inao T; Kotani H; Iida Y; Kartika ID; Okimoto T; Tanino R; Shiba E; Harada M
Cancer Sci; 2019 Sep; 110(9):2690-2699. PubMed ID: 31250942
[TBL] [Abstract][Full Text] [Related]
57. Size-dependent cytotoxicity of Fe3O4 nanoparticles induced by biphasic regulation of oxidative stress in different human hepatoma cells.
Xie Y; Liu D; Cai C; Chen X; Zhou Y; Wu L; Sun Y; Dai H; Kong X; Liu P
Int J Nanomedicine; 2016; 11():3557-70. PubMed ID: 27536098
[TBL] [Abstract][Full Text] [Related]
58. In vitro study on apoptotic cell death by effective magnetic hyperthermia with chitosan-coated MnFe₂O₄.
Oh Y; Lee N; Kang HW; Oh J
Nanotechnology; 2016 Mar; 27(11):115101. PubMed ID: 26871973
[TBL] [Abstract][Full Text] [Related]
59. Iron oxide nanoparticles cause surface coating- and core chemistry-dependent endothelial cell ferroptosis.
Zhang X; Kong F; Wang T; Huang X; Li W; Zhang M; Wen T; Liu J; Zhang Y; Meng J; Xu H
Nanotoxicology; 2022; 16(9-10):829-843. PubMed ID: 36660964
[TBL] [Abstract][Full Text] [Related]
60. A Comparative Study of Receptor-Targeted Magnetosome and HSA-Coated Iron Oxide Nanoparticles as MRI Contrast-Enhancing Agent in Animal Cancer Model.
Erdal E; Demirbilek M; Yeh Y; Akbal Ö; Ruff L; Bozkurt D; Cabuk A; Senel Y; Gumuskaya B; Algın O; Colak S; Esener S; Denkbas EB
Appl Biochem Biotechnol; 2018 May; 185(1):91-113. PubMed ID: 29082480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
